Denali Therapeutics (DNLI) Earnings Date & Reports

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DNLI is expected to report earnings to rise 4.30% to -69 cents per share on May 13

Denali Therapeutics DNLI Stock Earnings Reports

Q1'25

Est.

$-0.70

Q4'24

Beat

by $0.17

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.08

Q1'24

Beat

by $0.02

The last earnings report on February 27 showed earnings per share of -67 cents, beating the estimate of -83 cents. With 411.14K shares outstanding, the current market capitalization sits at 2.42B.

View a ticker or compare two or three

Compare

DNLI